UnitedHealth has traditionally been a company investors saw as reliable, having not missed earnings estimates since the 2008 global financial crisis.

The selloff in UnitedHealth's stock was weighing on shares of its peers, as Humana Inc.'s (HUM) dropped 7.4%, CVS Health Corp.'s (CVS) were down 1.8%, Elevance Health Inc.'s slid 2.4% and Centene Corp ...

A surprising Medicare Advantage cost spike helped push UnitedHealth into a rare deep dive Thursday, after the health care ...

Elevance Health (ELV) stock slips amid pressure from UnitedHealth's (UNH) Q1 results, even as its own early Q1 2025 results ...

UnitedHealth said it was blindsided by rising medical costs as the first quarter closed, upending a forecast it had affirmed ...

Ten healthcare organizations were recognized on LinkedIn’s 2025 list of the best large employers for career growth. The ninth annual ranking evaluates companies with 5,000 or more global employees on ...

Baird downgraded Elevance Health (ELV) to Neutral from Outperform with a price target of $529, down from $625. The firm sees minimal ...

Elevance (ELV) stock thrives with fee-based plans, preventive care, and disciplined capital management, ensuring growth and strong investor returns. See more.

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

Guggenheim initiated coverage of Elevance Health (ELV) with a Buy rating and $518 price target The firm launched coverage on 11 healthcare ...